Clinical Trials in Southport, Queensland

1 recruiting

Showing 19 of 9 trials

Recruiting
Phase 1Phase 2

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Metastatic Solid TumorSolid Tumor, AdultUnresectable Solid Tumor+1 more
Frontier Medicines Corporation403 enrolled26 locationsNCT06244771
Recruiting
Phase 3

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Breast Cancer
Stemline Therapeutics, Inc.4,220 enrolled524 locationsNCT06492616
Recruiting
Phase 2

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Advanced Solid TumorsHER2 Mutation
Bayer111 enrolled54 locationsNCT06760819
Recruiting
Phase 3

A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)

Breast Neoplasm FemaleRadiotherapyCosmetic Outcome
Ontario Clinical Oncology Group (OCOG)910 enrolled27 locationsNCT05417516
Recruiting
Early Phase 1

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

PDL1 Gene Mutation
Radiopharm Theranostics, Ltd30 enrolled5 locationsNCT06305962
Recruiting
Phase 1

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

OncoNano Medicine, Inc.168 enrolled16 locationsNCT06022029
Recruiting
Phase 3

Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial

Breast CancerMastectomyBreast Cancer Female+1 more
Monash University4,300 enrolled45 locationsNCT05072314
Recruiting
Phase 1

A Study of DM001 in Patients With Advanced Solid Tumors

Breast Neoplasms
Xadcera Biopharmaceutical (Suzhou) Co., Ltd.128 enrolled5 locationsNCT06475937
Recruiting
Phase 1

PRIME_LUNG: Primary Radiotherapy In MEtastatic Lung Cancer - A Pilot Study

NSCLC
Peter MacCallum Cancer Centre, Australia40 enrolled6 locationsNCT05222087